BeyondSpring to Present at Two Upcoming Scientific Conferences in December
24 nov. 2020 20h59 HE
|
BeyondSpring, Inc.
BeyondSpring to present at the 62nd American Society of Hematology (ASH) Annual Meeting and at the 2020 San Antonio Breast Cancer Symposium NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) --...
BeyondSpring to Participate in Upcoming Evercore ISI 2020 Conference
23 nov. 2020 16h01 HE
|
BeyondSpring, Inc.
NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology...
BeyondSpring Announces Pricing of Ordinary Shares
19 nov. 2020 08h00 HE
|
BeyondSpring, Inc.
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company focused on the development of innovative cancer...
BeyondSpring Announces Proposed Public Offering of Ordinary Shares
17 nov. 2020 16h01 HE
|
BeyondSpring, Inc.
NEW YORK, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company focused on the development of innovative cancer...
BeyondSpring Announces Third Quarter 2020 Financial Results and Provides Business Updates
17 nov. 2020 08h00 HE
|
BeyondSpring, Inc.
- Announced SEED Therapeutics Inc.(“SEED”)’s collaboration with Eli Lilly and Company(“Lilly”) NEW YORK, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”)...
BeyondSpring Announces Positive Topline Results from its PROTECTIVE-2 Phase 3 Registrational Trial of Plinabulin in Combination with Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia
16 nov. 2020 07h00 HE
|
BeyondSpring, Inc.
Study met primary endpoint showing statistically significant improvement in rate of prevention of Grade 4 neutropenia in Cycle 1, p=0.0015Study met statistically significant improvement in key...
BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference
13 nov. 2020 16h46 HE
|
BeyondSpring, Inc.
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology...
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
13 nov. 2020 07h00 HE
|
BeyondSpring, Inc.
- Seed Therapeutics to Use Proprietary “Molecular Glue” Protein Degradation Technology to Develop Potential New Medicines - NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Seed Therapeutics (“the...
Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer
14 oct. 2020 07h00 HE
|
BeyondSpring, Inc.
NEW YORK, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Seed Therapeutics Inc. (the “Company” or “Seed Therapeutics”), a global research company and BeyondSpring subsidiary focused on harnessing and engineering...
BeyondSpring Forms Partnership Advisory Committee Comprised of Industry Veterans
12 oct. 2020 07h00 HE
|
BeyondSpring, Inc.
NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative...